Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350600
Max Phase: Preclinical
Molecular Formula: C51H66N12O11
Molecular Weight: 1023.16
Molecule Type: Small molecule
Associated Items:
ID: ALA3350600
Max Phase: Preclinical
Molecular Formula: C51H66N12O11
Molecular Weight: 1023.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)c1cc(CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)cc(Cc2ccc(O)cc2)c1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
Standard InChI: InChI=1S/C51H66N12O11/c1-3-29(2)43(48(71)60-39(24-35-27-55-28-58-35)49(72)63-18-8-12-41(63)47(70)61-40(50(73)74)23-30-9-5-4-6-10-30)62-44(67)34-21-32(19-31-13-15-36(64)16-14-31)20-33(22-34)26-57-46(69)38(11-7-17-56-51(53)54)59-45(68)37(52)25-42(65)66/h4-6,9-10,13-16,20-22,27-29,37-41,43,64H,3,7-8,11-12,17-19,23-26,52H2,1-2H3,(H,55,58)(H,57,69)(H,59,68)(H,60,71)(H,61,70)(H,62,67)(H,65,66)(H,73,74)(H4,53,54,56)/t29-,37-,38-,39-,40-,41-,43-/m0/s1
Standard InChI Key: IXDDGYTURTZTQP-WBRWVFDESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1023.16 | Molecular Weight (Monoisotopic): 1022.4974 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Georgsson J, Sköld C, Plouffe B, Lindeberg G, Botros M, Larhed M, Nyberg F, Gallo-Payet N, Gogoll A, Karlén A, Hallberg A.. (2005) Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity., 48 (21): [PMID:16220978] [10.1021/jm050280z] |
Source(1):